NCT05576831View on ClinicalTrials.gov

STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision

NANot yet recruitingINTERVENTIONAL
Enrollment

249

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Vulvar Cancer
Interventions
PROCEDURE

Re-excision

Re-excise (one take back only) Excise scar aiming for 1-2cm margin

Trial Locations (1)

V5Z 2E6

BC Cancer - Vancouver Centre, Vancouver

All Listed Sponsors
collaborator

Gynecologic Cancer Initiative

OTHER

collaborator

Australia New Zealand Gynaecological Oncology Group

OTHER

collaborator

Canadian Cancer Trials Group

NETWORK

lead

British Columbia Cancer Agency

OTHER